Transcription factor MEF2A mutations in patients with coronary artery disease.
about
Molecular genetics of coronary artery diseaseAdvances in the genetic basis of coronary artery diseaseGenetics of coronary artery disease and myocardial infarctionWhole-exome sequencing of a pedigree segregating asthma.Lack of MEF2A Delta7aa mutation in Irish families with early onset ischaemic heart disease, a family based studyGATA2 is associated with familial early-onset coronary artery disease.Lack of MEF2A mutations in coronary artery disease.Identifying novel genes for atherosclerosis through mouse-human comparative genetics.Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis.Association of MEF2A gene polymorphisms with coronary artery diseaseAssociation Study between Coronary Artery Disease and rs1333049 and rs10757274 Polymorphisms at 9p21 Locus in South-West IranRNA interference of myocyte enhancer factor 2A accelerates atherosclerosis in apolipoprotein E-deficient mice.The genetics of heart attackGenetic and genomic insights into the molecular basis of atherosclerosis.Genetic susceptibility to myocardial infarction and coronary artery disease.Identification of atherosclerosis-modifying genes: pathogenic insights and therapeutic potential.Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery diseaseCross-Tissue Regulatory Gene Networks in Coronary Artery DiseaseRapid recruitment of temporally distinct vascular gene sets by estrogenNovel 6-bp deletion in MEF2A linked to premature coronary artery disease in a large Chinese familyLack of Association between the MEF2A Gene and Coronary Artery Disease in Iranian Families.Novel roles of GATA1 in regulation of angiogenic factor AGGF1 and endothelial cell function.Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling.Mef2s are required for thick filament formation in nascent muscle fibres.Requirements of myocyte-specific enhancer factor 2A in zebrafish cardiac contractility.Genetic susceptibility to atherosclerosisValues for free/total prostate-specific antigen ratio as a function of age: necessity of reference validation in a Turkish population.Promoter variant-dependent mRNA expression of the MEF2A in longissimus dorsi muscle in cattle.MEF2A sequence variants and coronary artery disease: a change of heart?Miscues on the "lack of MEF2A mutations" in coronary artery disease.The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction.CAG repeat polymorphism of the MEF2A gene is not associated with the risk of coronary artery disease among Taiwanese.Response to Wang et al.Generation of a mef2aa:EGFP transgenic zebrafish line that expresses EGFP in muscle cells.Mapping genetic variants for cranial vault shape in humans.
P2860
Q24674808-DA80A7E4-3772-41B4-AEB2-E673C860DFA3Q24682029-C60D5D18-7796-4F3A-A467-FF6DFCEF06CCQ26769994-59895817-F819-4DDC-BC63-18CB28A63C4EQ30458323-5AA4B2F2-1AFA-4118-92E7-7D7C8650031CQ33252031-43CAF773-925E-41F9-A8EC-F33559B6FFCDQ33255348-8734E0CA-84E9-4D74-AF9A-388A494F48E2Q33726939-C953694F-6BA2-4817-92E8-DC73AE01DB7FQ34021005-56D55987-7541-4910-94C1-D95C05CB68BFQ34170897-9895510A-68A2-420E-814E-0598ED4D894CQ34461392-754A1298-9ED6-4E6B-8C56-90481FDA7E0DQ35369571-6CEBD8C2-0527-4B7A-AA97-5CD05FADF891Q35582289-BE70321D-4721-440C-8DE1-5AB4100698CAQ35770844-F6E41F1F-5A22-4B44-A809-15735FE9293FQ36155114-55BDDA99-2218-4F75-878D-B5675C6980DCQ36599259-FC9E208D-9C02-498A-AF02-C2BCF4467387Q36642686-D5D5651C-8A82-4ACA-8A25-8A698C424A3FQ36678689-AF6C05E8-8A50-49B8-87CE-BA8AC3E25329Q36865220-A1BE427D-49C6-4E68-A2EE-6412E87D1EC1Q36971858-0C12825D-5A90-44B7-AF31-B8662DAE9D9BQ37032244-DBF92F65-F2B5-43C7-A3E5-8CC192BFBF88Q37205068-F2C52865-43B2-4406-80E9-B3143F845348Q37358087-793E8682-3A71-47EB-840D-F384A55E1FB8Q37368686-50D271A4-C127-49B8-A1E4-9D2AF23915FAQ38301246-81E89085-1A8B-4E09-A4D1-FAB8698EF034Q38322027-B797B757-2046-4C72-8CB9-14EE0825C21AQ39622383-FE182744-9D26-45F6-9CF4-5D09AFDFB500Q39804132-7E002BE1-5092-4F38-98E5-03FC7B90C555Q41980760-BE693289-5610-4247-BB26-BDCE4B5BC441Q42710739-9C54622D-141B-4535-81EC-29837427DD77Q42827539-4B564692-B62F-468C-8A8F-5FDE92E9972EQ43100237-6A9A6BF5-D761-4077-A55C-37A3230A614EQ45803793-D8005658-6B47-404F-A41E-F3D9729838B2Q46185764-56FF3C8D-8B56-4C4D-A2FE-46820BB76761Q48353193-CE55F26D-2611-4710-9350-7B7E50274B1EQ55004183-AC0F87AB-334B-41D3-B137-D2929CCCD645
P2860
Transcription factor MEF2A mutations in patients with coronary artery disease.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Transcription factor MEF2A mutations in patients with coronary artery disease.
@ast
Transcription factor MEF2A mutations in patients with coronary artery disease.
@en
type
label
Transcription factor MEF2A mutations in patients with coronary artery disease.
@ast
Transcription factor MEF2A mutations in patients with coronary artery disease.
@en
prefLabel
Transcription factor MEF2A mutations in patients with coronary artery disease.
@ast
Transcription factor MEF2A mutations in patients with coronary artery disease.
@en
P2093
P2860
P356
P1476
Transcription factor MEF2A mutations in patients with coronary artery disease.
@en
P2093
Edward F Plow
Gong-Qing Shen
June Cassano
M R Krishna Bhagavatula
P2860
P304
P356
10.1093/HMG/DDH329
P50
P577
2004-10-20T00:00:00Z